whats the difference between semaglutide or tirzepatide vs semaglutide: dual GLP-1 and GIP agonist Weight loss isn't one-size-fits-all. Both

(4) In contract, Ipamorelin has virtually no adverse side effects , meaning therapy protocols can be more aggressive

This synergistic effect is likely why tirzepatide (a dual GIP/GLP-1 agonist) outperforms semaglutide (GLP-1 only) in clinical trials Neuroprotective potential Preclinical research suggests GIP receptor activation may have protective effects on brain neurons, though this requires further human study Glucagon Receptor Activation: Retatrutides Unique Advantage The glucagon receptor is what sets retatrutide apart from every other weight loss medication currently available or in late-stage development

It also depends on the frequency at which you get B12 shots

Updated December 22, 2025